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Helicobacter pylori, a Gram-negative bacterial pathogen prevalent in the human
population, is the causative agent of severe gastric diseases. AnH. pylori type IV
secretion (T4S) system encoded by the cytotoxin-associated gene pathogenicity
island (cagPAI) is responsible for communication with host cells. As a
component of the cagPAI T4S system core complex, CagX plays an important
role in virulence-protein translocation into the host cells. In this work, the crystal
structure of the C-terminal domain of CagX (CagXct), which is a homologue of
the VirB9 protein from the VirB/D4 T4S system, is presented. CagXct is only the
second three-dimensional structure to be elucidated of a VirB9-like protein.
Another homologue, TraO, which is encoded on the Escherichia coli conjugative
plasmid pKM101, shares only 19% sequence identity with CagXct; however,
there is a remarkable similarity in tertiary structure between these two
-sandwich protein domains. Most of the residues that are conserved between
CagXct and TraO are located within the protein core and appear to be
responsible for the preservation of this domain fold. The studies presented here
will contribute to our understanding of different bacterial T4S systems.
1. Introduction
Helicobacter pylori is a Gram-negative bacterial pathogen
which lives in the stomachs of more than half of the population
of the world and causes chronic gastritis, peptic ulcers, gastric
adenocarcinoma and gastric lymphoma (Blaser, 1997; Blaser
& Atherton, 2004; Covacci et al., 1999; Parsonnet et al., 1994).
The cytotoxin-associated gene pathogenicity island (cagPAI)
contains a 40 kb foreign DNA region which is considered to
be the main genetic determinant of more virulent H. pylori
strains (Backert et al., 2002; Blaser & Atherton, 2004). The
cagPAI carries 27 genes which encode several effector
proteins and one type IV secretion (T4S) system. T4S systems
are important nanomachines in Gram-negative bacteria which
play important roles in various biological processes from the
transfer of virulence factors into eukaryotic cells to the
conjugative delivery of genetic material and the uptake or
release of DNA (Cascales & Christie, 2003). The T4S system
of H. pylori translocates the major effector protein CagA into
gastric epithelial cells. Subsequent phosphorylation of intra-
cellular CagA leads to epithelial cell elongation and disruption
of tight junctions, which results in the pathogenicity of
H. pylori (Backert et al., 2002; Blaser & Atherton, 2004;
Odenbreit et al., 2000; Segal et al., 1997; Backert & Selbach,
2008). The T4S system has been visualized at the surface
between H. pylori and gastric epithelial cells, forming a
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needle-like structure crossing the inner and outer membranes
(Zanotti & Cendron, 2014). It has been proposed that the
transmembrane core complex of the H. pylori cagPAI T4S
system is formed by CagY, CagTand CagX, while the external
pilus is thought to be composed of a large number of copies of
CagC and CagL (Fischer, 2011; Terradot & Waksman, 2011).
As an essential component of the cagPAI T4S system core
complex, CagX plays a critical role in CagA translocation into
the host cell. Genetic and functional studies have indicated
that the ability of H. pylori to translocate CagA into gastric
cells is abrogated by inactivation of CagX (hp0528; Akopyants
et al., 1998; Censini et al., 1996; Li et al., 1999; Fischer et al.,
2001). The C-terminal domain of CagX has been shown to be
responsible for its interaction with CagT by co-immuno-
precipitation, MBP pull-down and yeast two-hybrid assays
(Gopal et al., 2015).
CagX is presumed to be structurally and functionally
homologous to VirB9 from the well studied VirB/D4 T4S of
the plant pathogen Agrobacterium tumefaciens, although the
two proteins have low sequence identity (Bayliss et al., 2007;
Christie et al., 2005; Censini et al., 1996). While VirB9 forms
a heterotrimer with VirB7 and VirB10 in the VirB/D4 T4S
system, it is proposed that CagX associates not only with CagT
and CagY, but also with CagM and Cag, to form a trans-
membrane core complex in the cagPAI T4S system (Kutter et
al., 2008; Pinto-Santini & Salama, 2009).
Here, we report the expression, puriﬁcation, crystallization,
structure determination and analysis of the C-terminal domain
of the CagX protein (CagXct). This important component of
the cagPAI T4S system folds into a -sandwich domain
containing nine -strands. It is the ﬁrst structure of a
component of the transmembrane core complex of the cagPAI
T4S system to be determined, and is only the second three-
dimensional structure of a VirB9 homologue. The crystal
structure was determined by the molecular-replacement
method and reﬁned at a resolution of 1.4 A˚. Comparison of
the CagXct structure with that of the C-terminal domain of
another VirB9 homologue, TraO, which is a part of the outer
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Table 1
Cloning of expression constructs.
Source organism H. pylori
DNA source cDNA isolated from H. pylori 26695
Forward primer (FCagXct-EcoRI) CCGGAATTCCCCGTGCCTAGAAACTACAACTAC
Reverse primer (NCagXct-XhoI) CCGCTCGAGTTATGTCAATGGATTTTTCCCAT-
AGCC
Cloning vector pET-32a
Expression vector pET-32a
Expression host E. coli BL21 (DE3)
Complete amino-acid sequence of
the construct product
PVPRNYNYYQAPEKRSKHIMPSEIFDDGTFTY-
FGFKNITLQPAIFVVQPDGKLSMTDAAIDP-
NMTNSGLRWYRVNEIAEKFKLIKDKALVTV-
INKGYGKNPLT
Figure 1
15% SDS–PAGE analysis of puriﬁed CagXct stained with Coomassie
Brilliant Blue. Lane A, non-induced expression strains. Lane a, induced
expression strains. Lane B, pellet fractions. Lane b, supernatant fractions.
Lane 1, eluted with 500 mM imidazole; the band containing CagXct with
a Trx tag is around 35 kDa. Lane 2, after cleavage by TEV; the band
containing CagXct is under 14.4 kDa. Lane 3, ﬂowthrough of the second
nickel column. Lane 4, the sample before size-exclusion chromatography,
showing high purity. LaneM contains molecular-mass marker (labelled in
kDa).
Figure 2
(a) Size-exclusion chromatography trace (HiLoad 16/600 Superdex 200
75 pg; GE Healthcare). CagXct elutes at 80–110 ml, which is in agreement
with its monomer molecular mass of 11.4 kDa. The peak intensity is
192 mAU. Samples between 80 and 110 ml labelled 3–17 in red were
picked for 15% SDS–PAGE analysis. (b) 15% SDS–PAGE analysis of the
puriﬁed CagXct samples labelled 3, 5, 9, 11, 13, 15 and 17 in (a). Lane M
contains molecular-mass marker (labelled in kDa).
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membrane complex encoded by the Escherichia coli conju-
gative plasmid pKM101, suggests the possible conservation of
some protein–protein interactions between the pKM101 T4S
system and the cagPAI T4S system.
2. Materials and methods
2.1. Cloning of expression constructs and protein expression
The gene encoding the soluble fragment of Hp0528 (amino
acids 396–498; CagXct) was ampliﬁed from Hp26695 genomic
DNA using the primer pair FCagXct/NCagXct and subcloned
into pET-32a vector via EcoRI and XhoI (Table 1). The
constructed pET-32a-CagXct was transformed into E. coli
BL21 (DE3) cells. Expression of CagXct was performed in LB
medium containing 100 mg ml1 ampicillin and the culture was
incubated at 37C and 220 rev min1 until an OD600 of 0.6–0.8
was reached. 0.3 mM isopropyl -d-1-thiogalactopyranoside
(IPTG) was added to induce the expression of recombinant
CagXct and the culture was left to shake for 12 h at 16C and
180 rev min1. The expression levels of CagXct were moni-
tored by SDS–PAGE (Fig. 1).
2.2. Protein purification and crystallization
The cells were harvested by centrifugation (7000 rev min1,
5 min), resuspended in a lysis buffer consisting of 50 mM Tris–
HCl pH 7.0, 500 mM NaCl, 5%(v/v) glycerol, 1 mM phenyl-
methylsulfonyl ﬂuoride (PMSF), 1%(v/v) Tween 20 and then
sonicated on ice (Scientz-IID). The recombinant protein was
puriﬁed from the supernatant by immobilized nickel-afﬁnity
column chromatography (GE Healthcare) and digested with
TEV protease to remove the His tag and Trx tag (Fig. 1b). The
fractions were analyzed by SDS–PAGE (Fig. 1). The puriﬁed
CagXct was then concentrated to 5 mg ml1 and applied onto
a size-exclusion chromatography column (HiLoad 16/600
Superdex 200 75 pg; GE Healthcare) in 25 mM Tris–HCl pH
7.0, 150 mMNaCl, 5% glycerol. The trace showed that most of
the CagXct eluted in a monomeric form (Fig. 2a). Fractions
were assessed by 15% SDS–PAGE (Fig. 2b).
The puriﬁed CagXct was concentrated and crystallized
using the sitting-drop vapour-diffusion method in 96-well
Intelli-Plates (Art Robbins Instruments). The crystallization
trials were set up with an ARI robot (Art Robbins Instru-
ments) using the following screens: Crystal Screen and Crystal
Screen 2 (Hampton Research) and The PEGs, JCSG and
Classics Suites (Qiagen). The drops had a total volume of 1 ml
and consisted of a 1:1 ratio of protein solution to precipitant.
The best crystals of CagXct grew from protein solution
concentrated to 70 mg ml1 with a precipitant consisting of
27% polyethylene glycol 4000, 100 mM HEPES pH 7.5, 10%
2-propanol.
2.3. Data collection and processing
Data were collected at 100 K on the BL17U1 beamline of
the Shanghai Synchrotron Radiation Facility (SSRF) at a
wavelength of 0.9792 A˚. The data were initially processed with
HKL-2000 (Otwinowski & Minor, 1997) and the CCP4 suite
(Winn et al., 2011) in the orthorhombic space group P212121,
with unit-cell parameters a = 33.1, b = 61.6, c = 48.4 A˚,
 =  =  = 90. Owing to problems in molecular repacement
(MR) and reﬁnement in this space group, the data were later
reprocessed as triclinic using DIALS (Waterman et al., 2016)
in the xia2 pipeline (Winter et al., 2013). The overall DIALS
Rmerge value decreased from 0.106 in P212121 to 0.050 in P1.
After the correct space group had been established by
the downstream reﬁnement as monoclinic P21 with unique
b = 61.6 A˚,  = 90.23, the data were reprocessed to 1.4 A˚
resolution in this space group with XDS (Kabsch, 2010) in the
xia2 pipeline (Table 2).
2.4. Structure solution and refinement
A promising MR solution was originally found in P212121
with the MrBUMP/Phaser pipeline (Keegan & Winn, 2008;
McCoy et al., 2007) using the structure of chain B (TraO) of the
E. coli pKM101 plasmid-encoded outer membrane complex as
a search model (Chandran et al., 2009; PDB entry 3jqo; 19%
sequence identity). The model, which contained one CagXct
molecule per asymmetric unit (41% solvent), was reﬁned
using REFMAC5 (Murshudov et al., 2011; Winn et al., 2001)
and rebuilt using Coot (Emsley et al., 2010). Missing protein
side chains were clearly visible in the electron density;
however, the rebuilt structure could not be reﬁned to an Rfree
value of below 0.38. An inspection of systematic absences
proved to be inconclusive regarding the screw/rotation char-
acter of the crystal axes, thereforeMoRDa (Vagin & Lebedev,
2015) was used to conduct MR and reﬁnement in every
possible orthorhombic space group. Surprisingly, high-scoring
solutions were found in several space groups; however, the
P212121 solution appeared to be the best since the MoRDa
solutions in other space groups had higher R factors.
Intensity statistics (L-test; Padilla & Yeates, 2003) imple-
mented in POINTLESS (Evans, 2011) suggested that the
research communications
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Table 2
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source BL17U1, SSRF
Wavelength (A˚) 0.97946
Temperature (K) 100
Detector ADSC Q315R
Rotation range per image () 1
Total rotation range () 180
Exposure time per image (s) 0.8
Space group P21
a, b, c (A˚) 33.1, 61.6, 48.4
, ,  () 90.00, 90.23, 90.00
Resolution range (A˚) 38.07–1.40 (1.44–1.40)
Total No. of reﬂections 130565
No. of unique reﬂections 34978
Completeness (%) 91.7 (56.0)
hI/(I)i 12.3 (3.0)
Rmerge (%)† 5.0 (34.7)
Multiplicity 3.7 (3.4)
CC1/2 0.997 (0.803)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) are the intensities
of the individual measurements of a given reﬂection hkl and hI(hkl)i is the average
intensity over all replicates of that reﬂection,
P
hkl is the sum over all reﬂections and
P
i
is the sum over i measurements of the reﬂection.
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CagXct crystal belonged to a lower symmetry space group and
was twinned. A distinct crystallographic dyad could not be
determined by the processing statistics, since the merging R
factors were close to 10% for each crystal axis.
To establish the true space group, the data were reprocessed
in P1. The MR solution (four protein monomers) in this space
group was found using MoRDa with PDB entry 3jqo chain B
as the model. The solution had a MoRDa Q-factor of 0.71, a
probability of correct solution of 99% and reﬁned to an Rfree
of 0.40 without any model rebuilding, with most of the amino-
acid side chains absent. The CCP4 program Zanuda (Lebedev
& Isupov, 2014) was applied to the partially reﬁned P1 model,
which had an Rfree of 0.32. The true space group, in which the
model reﬁned to the same R values, was monoclinic P21, with
unique b = 61.6 A˚,  = 90.23. The Rfree values were 0.38 or
higher in all other monoclinic and orthorhombic space groups.
SFCHECK (Vaguine et al., 1999) analysis of data reprocessed
in P21 clearly identiﬁed a nonmerohedral twinning operation
(h, k, l) with an obliquity of 0.23 and a twinning fraction
of 0.46. Twin isotropic B-factor reﬁnement of the CagXct
structure was performed with REFMAC. The atomic coordi-
nates and structure factors for the CagXct structure have been
deposited in the Protein Data Bank with accession code 5h3v.
3. Results and discussion
3.1. Cloning, overexpression, purification and crystallization
The soluble fragment (residues 396–498) of CagX was
successfully cloned and expressed in E. coli strain BL21 (DE3)
with a His tag and a Trx tag. The tags were removed by limited
proteolysis of CagXct bound to a nickel immobilized metal
ion-afﬁnity column using TEV protease. The protein was
further puriﬁed by a second run of nickel immobilized metal
ion-afﬁnity chromatography and size-exclusion chromato-
graphy. CagXct was concentrated to 70 mg ml1 and crystal-
lized by the vapour-diffusion method from PEG and
2-propanol.
3.2. Quality of the model
The CagXct crystal structure was solved by MR and
subjected to isotropic B-factor twin reﬁnement in REFMAC5
at 1.4 A˚ resolution after the true space group had been
established as monoclinic P21 with a  angle close to 90
, with
the crystal forming a nonmerohedral twin. The quality of the
electron-density maps was mostly acceptable, although some
ripples were observed in the Fo  Fc map calculated using the
detwinned data (Fig. 3). These ripples are likely to be caused
by crystal twinning since similar electron-density features have
been reported for other twinned and order–disorder crystal
structures (Lebedev et al., 2006; Rye et al., 2007). The CagXct
model was reﬁned to an R factor of 0.200 and an Rfree of 0.249
in space group P21 (Table 3). It contains two protein mono-
mers with all residues built into the electron density, one PEG
and two 2-propanol molecules and 129 waters. Many residue
side chains were modelled with alternative conformations. The
CagXct model contains no residues in the cis-conformation.
Asp481 in both monomers of CagXct is a Ramachandran plot
outlier, while Gly258 in the equivalent position in the TraO
structure has similar main-chain torsion angles. The two
monomers of CagXct comprising the asymmetric unit can be
superimposed with an r.m.s.d. of 0.38 A˚ over all 103 C atoms.
3.3. Overall structure
CagXct folds into a -sandwich domain formed by two
antiparallel -sheets containing nine -strands (Fig. 4).
-Sheet 1 contains strands 1, 4, 5, 8 and 9 and has
Richardson topology 3, 1, 2x, 1 (Richardson, 1981).
-Sheet 2 contains strands 2, 3, 6 and 7 and has topology
1, 2x, 1.
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Figure 3
Electron-density maps around -sheet 2 of CagXct monomer A. The
2Fo  Fc map (blue) is contoured at 1.4 and the Fo  Fc map is
contoured at 3.0 (green) and3.0 (red). The difference density ripples
(red and green) are likely to be owing to crystal twinning. This ﬁgure was
prepared using PyMOL (Schro¨dinger).
Table 3
Structure solution and reﬁnement of CagXct.
PDB code 5h3v
Resolution range (A˚) 38.07–1.40 (1.43–1.40)
Final Rcryst 0.200 (0.291)
Final Rfree 0.249 (0.442)
No. of twin domains 2
Twin fractions 0.509 (h, k, l), 0.491 (h, k, l)
L-test for twinning h|L|i = 0.40, hL2i = 0.22
R.m.s. deviations
Bonds (A˚) 0.012
Angles () 1.712
Wilson B factor (A˚2)† 20.2
No. of protein residues 206
No. of solvent atoms 145
Average B-factor values
Protein (A˚2) 15.0
Solvent (A˚2) 22.6
Ramachandran plot analysis‡
Most favoured (%) 85.2
Additionally allowed (%) 13.6
Generously allowed (%) 0.6
Disallowed 0.6
† The Wilson B factor was calculated using SFCHECK (Vaguine et al., 1999). ‡ The
Ramachandran plot analysis was performed by PROCHECK (Laskowski et al., 1993).
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The two independent CagXct monomers do not form any
oligomer between themselves or with their crystal symmetry
mates, which is in line with a monomer being the main species
in solution, as can be seen from the size-exclusion chromato-
graphy trace (Fig. 2a).
3.4. Comparison of CagXct with TraO
A DALI search (Holm & Rosenstro¨m, 2010) reveals that
the most similar structure to CagXct is the C-terminal domain
of the VirB9 homologue TraO (TraOct) from the crystal
structure of the pKM101 plasmid-encoded T4S outer
membrane complex (Chandran et al., 2009; PDB entry 3jqo;
chain B was used as an MR model with a sequence identity of
19%). This 0.6 MDa complex represents a 14-fold rotational
symmetry ring spanning the outer membrane which is formed
by the pKM101 T4S system proteins TraOct, TraN and TraFct.
An NMR structure is also available for TraO in complex with
another component of the pKM101 T4S system, the VirB7-
like TraN (PDB entry 3jqo; Chandran et al., 2009).
CagXct and TraOct are remarkably similar, despite their
low sequence identity (Figs. 5 and 6). The region 177–270 of
the TraO monomer (PDB entry 3jqo; chain B) aligns with the
CagXct monomer with an r.m.s.d. of 1.4 A˚ over 95% of the C
atoms. Such a high level of structural similarity may explain
the success of MR structure solution using the TraO model.
To maintain structural similarity, many buried protein
residues which form the protein core of TraO are conserved
or substituted by residues with similar properties in CagX.
Remarkably, most of these conserved residues retain the same
side-chain conformation (Fig. 6). Generally, it would appear
that the conservation of the overall fold/shape of the VirB9-
like domain is more important for the function of this member
of the T4S system than the preservation of speciﬁc individual
residues that may be involved in interactions with other
proteins forming the outer membrane complex of the T4S
system.
3.5. Conservation of protein–protein interactions in T4S
The structure of the outer membrane complex of the T4S
plasmid pKM101 (Chandran et al., 2009) provides insight into
the general architecture of bacterial T4S systems. A TraOct
domain in this ring structure interacts with two neighbouring
TraO monomers, two TraF monomers and a single TraN
monomer. Since relatively little is known about the inter-
actions of CagX with its partners in the H. pylori T4S system,
it is interesting to map the sequence/structure conservation
features between TraO and CagXct onto these monomer–
monomer interactions.
TraN is a long peptide which winds around TraO. It adds an
additional -strand to -sheet 1 of TraO, which is observed in
both the binary complex TraO–TraN and in the heterotrimeric
outer membrane complex. Most amino-acid residues of strand
1, which runs antiparallel to TraN in TraO, are not conserved
in CagX; however, the main chains of the matching residues of
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Figure 5
Anmino-acid sequence alignment of CagXct and TraOct. The secondary-
structure elements are indicated above and below the alignment,
respectively, as -strands and -helices (310-helices). Conserved residues
are shown in red boxes; matching amino acids with similar properties are
shown in blue boxes. The secondary-structure assignments were carried
out and the ﬁgure was produced using ESPript3 (Robert & Gouet, 2014).
Figure 4
A stereo diagram showing a cartoon representation of CagXct, with the -strands coloured green and loops coloured grey. The secondary-structure
elements of this -sandwich domain are numbered. Figs. 4 and 6 were prepared using CCP4mg (McNicholas et al., 2011).
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both these T4S proteins have the same conformation and
solvent accessibility. Thus, it appears likely that the -sheet
interaction between TraO and TraN is reproduced in the Cag–
CagT interface.
Interactions between different TraO monomers in the
14-fold ring of the outer membrane complex of T4S plasmid
pKM101 are not extensive and the residues involved in these
interactions do not appear to be conserved in CagX.
Interactions between TraO and the two monomers of TraF
in this complex are more extensive; however, there is little
conservation of amino-acid residues in this interface. Inter-
estingly, one of the 2-propanol molecules binds to the main-
chain N atom of the Ramachandran plot outlier Asp481 in
monomer A in the CagXct structure. The main-chain N atom
of the equivalent Gly258 in TraO forms a hydrogen bond to
the main-chain O atom of Gly364 in TraF, with the positions of
Gly364 and the 2-propanol ligand O atoms overlapping. This
may suggest the preservation of another main-chain inter-
action in the CagX–CagY interface.
The sequence pattern ‘xVxVxN’ (where x represents a
binding residue) is shared by both structures in the 9 strand
in TraO and CagXct, suggesting that the conserved non-
binding residues in this pattern may play a role in maintaining
the proper distance with the 1 strand in a spatial conﬁgura-
tion to ensure binding to a protein partner (Fig. 7). However,
the binding residues are not conserved in 9; Leu484, Thr486
and Ile488 in CagXct correspond to Val261, Gly263 and
Arg264 in TraO (Figs. 5 and 7). The diversity in binding resi-
dues should be determined by their different interacting
protein substrates.
CagXct is only the second VirB9 homologue for which a
three-dimensional structure has been elucidated. Its structure
will provide additional insight into binding and translocation
mechanisms of the transmembrane core complex in H. pylori
and other T4S systems.
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